nodes	percent_of_prediction	percent_of_DWPC	metapath
Rescinnamine—Voacamine—Vinorelbine—hematologic cancer	0.272	0.385	CrCrCtD
Rescinnamine—Voacamine—Vinblastine—hematologic cancer	0.218	0.308	CrCrCtD
Rescinnamine—Voacamine—Vincristine—hematologic cancer	0.218	0.308	CrCrCtD
Rescinnamine—ACE—Metabolism of Angiotensinogen to Angiotensins—ANPEP—hematologic cancer	0.00547	0.139	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of Angiotensinogen to Angiotensins—CTSZ—hematologic cancer	0.00547	0.139	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of Angiotensinogen to Angiotensins—MME—hematologic cancer	0.0027	0.0685	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of Angiotensinogen to Angiotensins—CMA1—hematologic cancer	0.00267	0.0677	CbGpPWpGaD
Rescinnamine—ACE—ACE Inhibitor Pathway—CMA1—hematologic cancer	0.00254	0.0645	CbGpPWpGaD
Rescinnamine—SLC18A2—hematopoietic system—hematologic cancer	0.00247	0.158	CbGeAlD
Rescinnamine—ACE—hematopoietic system—hematologic cancer	0.00168	0.108	CbGeAlD
Rescinnamine—SLC18A2—blood—hematologic cancer	0.00163	0.105	CbGeAlD
Rescinnamine—SLC18A2—Dopaminergic Neurogenesis—RET—hematologic cancer	0.00151	0.0384	CbGpPWpGaD
Rescinnamine—SLC18A2—Norepinephrine Neurotransmitter Release Cycle—SLC22A1—hematologic cancer	0.00147	0.0373	CbGpPWpGaD
Rescinnamine—ACE—Peptide hormone metabolism—ANPEP—hematologic cancer	0.00144	0.0365	CbGpPWpGaD
Rescinnamine—ACE—Peptide hormone metabolism—CTSZ—hematologic cancer	0.00144	0.0365	CbGpPWpGaD
Rescinnamine—SLC18A2—lung—hematologic cancer	0.00143	0.0919	CbGeAlD
Rescinnamine—SLC18A2—Na+/Cl- dependent neurotransmitter transporters—SLC22A1—hematologic cancer	0.00141	0.0357	CbGpPWpGaD
Rescinnamine—SLC18A2—testis—hematologic cancer	0.00135	0.0867	CbGeAlD
Rescinnamine—ACE—gonad—hematologic cancer	0.00128	0.0821	CbGeAlD
Rescinnamine—Reserpine—SLC22A1—hematologic cancer	0.00113	0.548	CrCbGaD
Rescinnamine—ACE—blood—hematologic cancer	0.00112	0.0715	CbGeAlD
Rescinnamine—ACE—bone marrow—hematologic cancer	0.00108	0.0692	CbGeAlD
Rescinnamine—SLC18A2—lymph node—hematologic cancer	0.00098	0.0628	CbGeAlD
Rescinnamine—ACE—lung—hematologic cancer	0.000978	0.0627	CbGeAlD
Rescinnamine—SLC18A2—Amine compound SLC transporters—SLC22A1—hematologic cancer	0.000976	0.0248	CbGpPWpGaD
Rescinnamine—ACE—testis—hematologic cancer	0.000923	0.0592	CbGeAlD
Rescinnamine—SLC18A2—Neurotransmitter Release Cycle—SLC22A1—hematologic cancer	0.000745	0.0189	CbGpPWpGaD
Rescinnamine—ACE—Peptide hormone metabolism—MME—hematologic cancer	0.00071	0.018	CbGpPWpGaD
Rescinnamine—ACE—Peptide hormone metabolism—CMA1—hematologic cancer	0.000702	0.0178	CbGpPWpGaD
Rescinnamine—ACE—lymph node—hematologic cancer	0.000669	0.0429	CbGeAlD
Rescinnamine—Voacamine—ABCB1—hematologic cancer	0.000601	0.293	CrCbGaD
Rescinnamine—ACE—ACE Inhibitor Pathway—TGFB1—hematologic cancer	0.000512	0.013	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—LDHD—hematologic cancer	0.000421	0.0107	CbGpPWpGaD
Rescinnamine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A1—hematologic cancer	0.000382	0.00968	CbGpPWpGaD
Rescinnamine—Reserpine—ABCB1—hematologic cancer	0.000327	0.159	CrCbGaD
Rescinnamine—ACE—Metabolism of proteins—GCNT4—hematologic cancer	0.000319	0.00809	CbGpPWpGaD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—SLC35B2—hematologic cancer	0.000294	0.00746	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—ANPEP—hematologic cancer	0.000271	0.00688	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—CTSZ—hematologic cancer	0.000271	0.00688	CbGpPWpGaD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—SLC26A4—hematologic cancer	0.000262	0.00665	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—DPM1—hematologic cancer	0.000255	0.00647	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—ASNS—hematologic cancer	0.000255	0.00647	CbGpPWpGaD
Rescinnamine—SLC18A2—Dopaminergic Neurogenesis—STAT3—hematologic cancer	0.000232	0.00588	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—PREB—hematologic cancer	0.000231	0.00585	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—GCNT1—hematologic cancer	0.000221	0.00561	CbGpPWpGaD
Rescinnamine—SLC18A2—Dopaminergic Neurogenesis—TGFB1—hematologic cancer	0.000215	0.00545	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—SLC22A1—hematologic cancer	0.000214	0.00543	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—AQP9—hematologic cancer	0.000212	0.00538	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—FXYD6—hematologic cancer	0.000197	0.00501	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—ADCY7—hematologic cancer	0.000196	0.00497	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—MUC1—hematologic cancer	0.000188	0.00477	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—CAMK2D—hematologic cancer	0.000174	0.00442	CbGpPWpGaD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—SLC22A1—hematologic cancer	0.000173	0.0044	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—RPLP1—hematologic cancer	0.000164	0.00417	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—SLC22A1—hematologic cancer	0.000164	0.00416	CbGpPWpGaD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—NUP98—hematologic cancer	0.000164	0.00415	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—S100A10—hematologic cancer	0.000161	0.00408	CbGpPWpGaD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—NUP214—hematologic cancer	0.000158	0.004	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—TUBB2A—hematologic cancer	0.000151	0.00383	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—ADCY7—hematologic cancer	0.00015	0.00381	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	0.000149	0.00379	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	0.000141	0.00357	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—MME—hematologic cancer	0.000134	0.0034	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—CAMK2D—hematologic cancer	0.000134	0.00339	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	0.000133	0.00338	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—SUMO1—hematologic cancer	0.000132	0.00336	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—CMA1—hematologic cancer	0.000132	0.00336	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—SPHK1—hematologic cancer	0.00013	0.00329	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—ATP4A—hematologic cancer	0.000122	0.00309	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—SGK1—hematologic cancer	0.000122	0.00309	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—ANXA2—hematologic cancer	0.000122	0.00309	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—RPS14—hematologic cancer	0.000116	0.00295	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—PRKCG—hematologic cancer	0.00011	0.0028	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	0.00011	0.00278	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—EIF4EBP1—hematologic cancer	0.000102	0.00258	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—ABCC3—hematologic cancer	9.63e-05	0.00244	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—HSPA5—hematologic cancer	9.39e-05	0.00238	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—CALR—hematologic cancer	9.1e-05	0.00231	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	8.81e-05	0.00224	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—FBXW7—hematologic cancer	8.8e-05	0.00223	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—PRKCG—hematologic cancer	8.45e-05	0.00214	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—NUP98—hematologic cancer	8.32e-05	0.00211	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—CREB1—hematologic cancer	8.16e-05	0.00207	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—ADCY7—hematologic cancer	8.07e-05	0.00205	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—BRAF—hematologic cancer	8.06e-05	0.00205	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—NUP214—hematologic cancer	8.02e-05	0.00203	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—ABCG2—hematologic cancer	7.85e-05	0.00199	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—TFRC—hematologic cancer	7e-05	0.00178	CbGpPWpGaD
Rescinnamine—Myalgia—Triamcinolone—hematologic cancer	6.94e-05	0.000294	CcSEcCtD
Rescinnamine—Hypersensitivity—Alitretinoin—hematologic cancer	6.92e-05	0.000294	CcSEcCtD
Rescinnamine—Rash—Bortezomib—hematologic cancer	6.9e-05	0.000293	CcSEcCtD
Rescinnamine—Dermatitis—Bortezomib—hematologic cancer	6.9e-05	0.000293	CcSEcCtD
Rescinnamine—Headache—Bortezomib—hematologic cancer	6.86e-05	0.000291	CcSEcCtD
Rescinnamine—Discomfort—Triamcinolone—hematologic cancer	6.86e-05	0.000291	CcSEcCtD
Rescinnamine—Rash—Bleomycin—hematologic cancer	6.85e-05	0.000291	CcSEcCtD
Rescinnamine—Gastritis—Doxorubicin—hematologic cancer	6.85e-05	0.000291	CcSEcCtD
Rescinnamine—Pain—Cisplatin—hematologic cancer	6.85e-05	0.00029	CcSEcCtD
Rescinnamine—Dermatitis—Bleomycin—hematologic cancer	6.84e-05	0.00029	CcSEcCtD
Rescinnamine—Hypersensitivity—Ifosfamide—hematologic cancer	6.84e-05	0.00029	CcSEcCtD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—MDM2—hematologic cancer	6.75e-05	0.00171	CbGpPWpGaD
Rescinnamine—Dizziness—Thiotepa—hematologic cancer	6.75e-05	0.000286	CcSEcCtD
Rescinnamine—Rash—Vinorelbine—hematologic cancer	6.74e-05	0.000286	CcSEcCtD
Rescinnamine—Dermatitis—Vinorelbine—hematologic cancer	6.73e-05	0.000286	CcSEcCtD
Rescinnamine—Headache—Vinorelbine—hematologic cancer	6.7e-05	0.000284	CcSEcCtD
Rescinnamine—Conjunctivitis—Methotrexate—hematologic cancer	6.7e-05	0.000284	CcSEcCtD
Rescinnamine—Influenza—Doxorubicin—hematologic cancer	6.69e-05	0.000284	CcSEcCtD
Rescinnamine—Hypersensitivity—Vincristine—hematologic cancer	6.67e-05	0.000283	CcSEcCtD
Rescinnamine—Oedema—Triamcinolone—hematologic cancer	6.65e-05	0.000282	CcSEcCtD
Rescinnamine—Pruritus—Alitretinoin—hematologic cancer	6.65e-05	0.000282	CcSEcCtD
Rescinnamine—Infection—Triamcinolone—hematologic cancer	6.61e-05	0.00028	CcSEcCtD
Rescinnamine—Photosensitivity reaction—Epirubicin—hematologic cancer	6.6e-05	0.00028	CcSEcCtD
Rescinnamine—Paraesthesia—Etoposide—hematologic cancer	6.59e-05	0.000279	CcSEcCtD
Rescinnamine—Pruritus—Ifosfamide—hematologic cancer	6.57e-05	0.000279	CcSEcCtD
Rescinnamine—Insomnia—Prednisolone—hematologic cancer	6.54e-05	0.000277	CcSEcCtD
Rescinnamine—Dizziness—Thalidomide—hematologic cancer	6.53e-05	0.000277	CcSEcCtD
Rescinnamine—Angina pectoris—Doxorubicin—hematologic cancer	6.52e-05	0.000276	CcSEcCtD
Rescinnamine—Nausea—Bortezomib—hematologic cancer	6.5e-05	0.000276	CcSEcCtD
Rescinnamine—Hypersensitivity—Mitoxantrone—hematologic cancer	6.5e-05	0.000276	CcSEcCtD
Rescinnamine—Hypersensitivity—Irinotecan—hematologic cancer	6.5e-05	0.000276	CcSEcCtD
Rescinnamine—Paraesthesia—Prednisolone—hematologic cancer	6.5e-05	0.000275	CcSEcCtD
Rescinnamine—Nausea—Bleomycin—hematologic cancer	6.45e-05	0.000274	CcSEcCtD
Rescinnamine—Erythema—Prednisone—hematologic cancer	6.44e-05	0.000273	CcSEcCtD
Rescinnamine—Rash—Thiotepa—hematologic cancer	6.44e-05	0.000273	CcSEcCtD
Rescinnamine—Bronchitis—Doxorubicin—hematologic cancer	6.43e-05	0.000273	CcSEcCtD
Rescinnamine—Dermatitis—Thiotepa—hematologic cancer	6.43e-05	0.000273	CcSEcCtD
Rescinnamine—Headache—Thiotepa—hematologic cancer	6.4e-05	0.000271	CcSEcCtD
Rescinnamine—Hypertension—Betamethasone—hematologic cancer	6.39e-05	0.000271	CcSEcCtD
Rescinnamine—Hypertension—Dexamethasone—hematologic cancer	6.39e-05	0.000271	CcSEcCtD
Rescinnamine—Nausea—Vinorelbine—hematologic cancer	6.35e-05	0.000269	CcSEcCtD
Rescinnamine—Myalgia—Betamethasone—hematologic cancer	6.3e-05	0.000267	CcSEcCtD
Rescinnamine—Myalgia—Dexamethasone—hematologic cancer	6.3e-05	0.000267	CcSEcCtD
Rescinnamine—Dizziness—Carmustine—hematologic cancer	6.27e-05	0.000266	CcSEcCtD
Rescinnamine—Constipation—Etoposide—hematologic cancer	6.27e-05	0.000266	CcSEcCtD
Rescinnamine—Pain—Etoposide—hematologic cancer	6.27e-05	0.000266	CcSEcCtD
Rescinnamine—Conjunctivitis—Epirubicin—hematologic cancer	6.27e-05	0.000266	CcSEcCtD
Rescinnamine—Urinary tract infection—Epirubicin—hematologic cancer	6.27e-05	0.000266	CcSEcCtD
Rescinnamine—SLC18A2—Neuronal System—CREB1—hematologic cancer	6.25e-05	0.00159	CbGpPWpGaD
Rescinnamine—Rash—Thalidomide—hematologic cancer	6.23e-05	0.000264	CcSEcCtD
Rescinnamine—Discomfort—Dexamethasone—hematologic cancer	6.22e-05	0.000264	CcSEcCtD
Rescinnamine—Discomfort—Betamethasone—hematologic cancer	6.22e-05	0.000264	CcSEcCtD
Rescinnamine—Dermatitis—Thalidomide—hematologic cancer	6.22e-05	0.000264	CcSEcCtD
Rescinnamine—Dizziness—Alitretinoin—hematologic cancer	6.21e-05	0.000264	CcSEcCtD
Rescinnamine—Headache—Thalidomide—hematologic cancer	6.19e-05	0.000262	CcSEcCtD
Rescinnamine—Pain—Prednisolone—hematologic cancer	6.19e-05	0.000262	CcSEcCtD
Rescinnamine—SLC18A2—Neuronal System—BRAF—hematologic cancer	6.18e-05	0.00157	CbGpPWpGaD
Rescinnamine—Dizziness—Ifosfamide—hematologic cancer	6.14e-05	0.00026	CcSEcCtD
Rescinnamine—Pharyngitis—Methotrexate—hematologic cancer	6.14e-05	0.00026	CcSEcCtD
Rescinnamine—Photosensitivity reaction—Doxorubicin—hematologic cancer	6.11e-05	0.000259	CcSEcCtD
Rescinnamine—Pruritus—Gemcitabine—hematologic cancer	6.08e-05	0.000258	CcSEcCtD
Rescinnamine—Nausea—Thiotepa—hematologic cancer	6.06e-05	0.000257	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Triamcinolone—hematologic cancer	6.06e-05	0.000257	CcSEcCtD
Rescinnamine—Sinusitis—Epirubicin—hematologic cancer	6.05e-05	0.000256	CcSEcCtD
Rescinnamine—Oedema—Betamethasone—hematologic cancer	6.04e-05	0.000256	CcSEcCtD
Rescinnamine—Oedema—Dexamethasone—hematologic cancer	6.04e-05	0.000256	CcSEcCtD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—ALB—hematologic cancer	6.03e-05	0.00153	CbGpPWpGaD
Rescinnamine—Insomnia—Triamcinolone—hematologic cancer	6.02e-05	0.000255	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Etoposide—hematologic cancer	6e-05	0.000254	CcSEcCtD
Rescinnamine—Infection—Dexamethasone—hematologic cancer	6e-05	0.000254	CcSEcCtD
Rescinnamine—Infection—Betamethasone—hematologic cancer	6e-05	0.000254	CcSEcCtD
Rescinnamine—Dizziness—Vincristine—hematologic cancer	5.99e-05	0.000254	CcSEcCtD
Rescinnamine—Rash—Carmustine—hematologic cancer	5.98e-05	0.000254	CcSEcCtD
Rescinnamine—Dermatitis—Carmustine—hematologic cancer	5.97e-05	0.000253	CcSEcCtD
Rescinnamine—Paraesthesia—Triamcinolone—hematologic cancer	5.97e-05	0.000253	CcSEcCtD
Rescinnamine—Headache—Carmustine—hematologic cancer	5.94e-05	0.000252	CcSEcCtD
Rescinnamine—Rash—Alitretinoin—hematologic cancer	5.92e-05	0.000251	CcSEcCtD
Rescinnamine—Dermatitis—Alitretinoin—hematologic cancer	5.92e-05	0.000251	CcSEcCtD
Rescinnamine—Hypersensitivity—Cisplatin—hematologic cancer	5.9e-05	0.00025	CcSEcCtD
Rescinnamine—Headache—Alitretinoin—hematologic cancer	5.89e-05	0.00025	CcSEcCtD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—CYCS—hematologic cancer	5.87e-05	0.00149	CbGpPWpGaD
Rescinnamine—Nausea—Thalidomide—hematologic cancer	5.87e-05	0.000249	CcSEcCtD
Rescinnamine—Rash—Ifosfamide—hematologic cancer	5.86e-05	0.000248	CcSEcCtD
Rescinnamine—Dermatitis—Ifosfamide—hematologic cancer	5.85e-05	0.000248	CcSEcCtD
Rescinnamine—Dizziness—Irinotecan—hematologic cancer	5.83e-05	0.000247	CcSEcCtD
Rescinnamine—Urticaria—Etoposide—hematologic cancer	5.83e-05	0.000247	CcSEcCtD
Rescinnamine—Rhinitis—Epirubicin—hematologic cancer	5.8e-05	0.000246	CcSEcCtD
Rescinnamine—Abdominal pain—Etoposide—hematologic cancer	5.8e-05	0.000246	CcSEcCtD
Rescinnamine—Urinary tract infection—Doxorubicin—hematologic cancer	5.8e-05	0.000246	CcSEcCtD
Rescinnamine—Conjunctivitis—Doxorubicin—hematologic cancer	5.8e-05	0.000246	CcSEcCtD
Rescinnamine—Hypoaesthesia—Epirubicin—hematologic cancer	5.76e-05	0.000244	CcSEcCtD
Rescinnamine—Urticaria—Prednisolone—hematologic cancer	5.75e-05	0.000244	CcSEcCtD
Rescinnamine—Pharyngitis—Epirubicin—hematologic cancer	5.74e-05	0.000244	CcSEcCtD
Rescinnamine—Rash—Vincristine—hematologic cancer	5.71e-05	0.000242	CcSEcCtD
Rescinnamine—Dermatitis—Vincristine—hematologic cancer	5.7e-05	0.000242	CcSEcCtD
Rescinnamine—Pain—Triamcinolone—hematologic cancer	5.69e-05	0.000241	CcSEcCtD
Rescinnamine—Headache—Vincristine—hematologic cancer	5.67e-05	0.000241	CcSEcCtD
Rescinnamine—Nausea—Carmustine—hematologic cancer	5.63e-05	0.000239	CcSEcCtD
Rescinnamine—Sinusitis—Doxorubicin—hematologic cancer	5.6e-05	0.000237	CcSEcCtD
Rescinnamine—Nausea—Alitretinoin—hematologic cancer	5.58e-05	0.000237	CcSEcCtD
Rescinnamine—Hypertension—Prednisone—hematologic cancer	5.56e-05	0.000236	CcSEcCtD
Rescinnamine—Rash—Irinotecan—hematologic cancer	5.56e-05	0.000236	CcSEcCtD
Rescinnamine—Rash—Mitoxantrone—hematologic cancer	5.56e-05	0.000236	CcSEcCtD
Rescinnamine—Dermatitis—Mitoxantrone—hematologic cancer	5.55e-05	0.000236	CcSEcCtD
Rescinnamine—Dermatitis—Irinotecan—hematologic cancer	5.55e-05	0.000236	CcSEcCtD
Rescinnamine—Headache—Mitoxantrone—hematologic cancer	5.52e-05	0.000234	CcSEcCtD
Rescinnamine—Headache—Irinotecan—hematologic cancer	5.52e-05	0.000234	CcSEcCtD
Rescinnamine—Nausea—Ifosfamide—hematologic cancer	5.52e-05	0.000234	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	5.5e-05	0.000233	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Betamethasone—hematologic cancer	5.5e-05	0.000233	CcSEcCtD
Rescinnamine—Myalgia—Prednisone—hematologic cancer	5.48e-05	0.000233	CcSEcCtD
Rescinnamine—Insomnia—Dexamethasone—hematologic cancer	5.46e-05	0.000232	CcSEcCtD
Rescinnamine—Insomnia—Betamethasone—hematologic cancer	5.46e-05	0.000232	CcSEcCtD
Rescinnamine—Paraesthesia—Betamethasone—hematologic cancer	5.42e-05	0.00023	CcSEcCtD
Rescinnamine—Paraesthesia—Dexamethasone—hematologic cancer	5.42e-05	0.00023	CcSEcCtD
Rescinnamine—Discomfort—Prednisone—hematologic cancer	5.42e-05	0.00023	CcSEcCtD
Rescinnamine—Rash—Gemcitabine—hematologic cancer	5.42e-05	0.00023	CcSEcCtD
Rescinnamine—Dermatitis—Gemcitabine—hematologic cancer	5.41e-05	0.000229	CcSEcCtD
Rescinnamine—Hypersensitivity—Etoposide—hematologic cancer	5.4e-05	0.000229	CcSEcCtD
Rescinnamine—Erythema—Methotrexate—hematologic cancer	5.38e-05	0.000228	CcSEcCtD
Rescinnamine—Headache—Gemcitabine—hematologic cancer	5.38e-05	0.000228	CcSEcCtD
Rescinnamine—Nausea—Vincristine—hematologic cancer	5.38e-05	0.000228	CcSEcCtD
Rescinnamine—Rhinitis—Doxorubicin—hematologic cancer	5.37e-05	0.000228	CcSEcCtD
Rescinnamine—Hypersensitivity—Prednisolone—hematologic cancer	5.33e-05	0.000226	CcSEcCtD
Rescinnamine—Hypoaesthesia—Doxorubicin—hematologic cancer	5.33e-05	0.000226	CcSEcCtD
Rescinnamine—Pharyngitis—Doxorubicin—hematologic cancer	5.31e-05	0.000225	CcSEcCtD
Rescinnamine—Urticaria—Triamcinolone—hematologic cancer	5.28e-05	0.000224	CcSEcCtD
Rescinnamine—Dysgeusia—Methotrexate—hematologic cancer	5.27e-05	0.000224	CcSEcCtD
Rescinnamine—Oedema—Prednisone—hematologic cancer	5.26e-05	0.000223	CcSEcCtD
Rescinnamine—Nausea—Mitoxantrone—hematologic cancer	5.24e-05	0.000222	CcSEcCtD
Rescinnamine—Nausea—Irinotecan—hematologic cancer	5.24e-05	0.000222	CcSEcCtD
Rescinnamine—Infection—Prednisone—hematologic cancer	5.22e-05	0.000221	CcSEcCtD
Rescinnamine—Back pain—Methotrexate—hematologic cancer	5.21e-05	0.000221	CcSEcCtD
Rescinnamine—Pruritus—Etoposide—hematologic cancer	5.19e-05	0.00022	CcSEcCtD
Rescinnamine—SLC18A2—Neuronal System—MDM2—hematologic cancer	5.17e-05	0.00131	CbGpPWpGaD
Rescinnamine—Pain—Betamethasone—hematologic cancer	5.16e-05	0.000219	CcSEcCtD
Rescinnamine—Pain—Dexamethasone—hematologic cancer	5.16e-05	0.000219	CcSEcCtD
Rescinnamine—Nausea—Gemcitabine—hematologic cancer	5.1e-05	0.000216	CcSEcCtD
Rescinnamine—Rash—Cisplatin—hematologic cancer	5.05e-05	0.000214	CcSEcCtD
Rescinnamine—Dermatitis—Cisplatin—hematologic cancer	5.04e-05	0.000214	CcSEcCtD
Rescinnamine—Erythema—Epirubicin—hematologic cancer	5.04e-05	0.000214	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Dexamethasone—hematologic cancer	4.94e-05	0.000209	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Betamethasone—hematologic cancer	4.94e-05	0.000209	CcSEcCtD
Rescinnamine—Dysgeusia—Epirubicin—hematologic cancer	4.93e-05	0.000209	CcSEcCtD
Rescinnamine—Hypersensitivity—Triamcinolone—hematologic cancer	4.9e-05	0.000208	CcSEcCtD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—ABCB1—hematologic cancer	4.9e-05	0.00124	CbGpPWpGaD
Rescinnamine—Back pain—Epirubicin—hematologic cancer	4.87e-05	0.000207	CcSEcCtD
Rescinnamine—Dizziness—Etoposide—hematologic cancer	4.85e-05	0.000206	CcSEcCtD
Rescinnamine—Urticaria—Dexamethasone—hematologic cancer	4.8e-05	0.000203	CcSEcCtD
Rescinnamine—Urticaria—Betamethasone—hematologic cancer	4.8e-05	0.000203	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Prednisone—hematologic cancer	4.79e-05	0.000203	CcSEcCtD
Rescinnamine—Dizziness—Prednisolone—hematologic cancer	4.78e-05	0.000203	CcSEcCtD
Rescinnamine—Abdominal pain—Dexamethasone—hematologic cancer	4.77e-05	0.000202	CcSEcCtD
Rescinnamine—Abdominal pain—Betamethasone—hematologic cancer	4.77e-05	0.000202	CcSEcCtD
Rescinnamine—Nausea—Cisplatin—hematologic cancer	4.76e-05	0.000202	CcSEcCtD
Rescinnamine—Insomnia—Prednisone—hematologic cancer	4.75e-05	0.000202	CcSEcCtD
Rescinnamine—Paraesthesia—Prednisone—hematologic cancer	4.72e-05	0.0002	CcSEcCtD
Rescinnamine—Pruritus—Triamcinolone—hematologic cancer	4.71e-05	0.0002	CcSEcCtD
Rescinnamine—Cough—Methotrexate—hematologic cancer	4.7e-05	0.000199	CcSEcCtD
Rescinnamine—Erythema—Doxorubicin—hematologic cancer	4.66e-05	0.000198	CcSEcCtD
Rescinnamine—Rash—Etoposide—hematologic cancer	4.62e-05	0.000196	CcSEcCtD
Rescinnamine—Dermatitis—Etoposide—hematologic cancer	4.62e-05	0.000196	CcSEcCtD
Rescinnamine—Headache—Etoposide—hematologic cancer	4.59e-05	0.000195	CcSEcCtD
Rescinnamine—Myalgia—Methotrexate—hematologic cancer	4.58e-05	0.000194	CcSEcCtD
Rescinnamine—Dysgeusia—Doxorubicin—hematologic cancer	4.56e-05	0.000194	CcSEcCtD
Rescinnamine—Rash—Prednisolone—hematologic cancer	4.56e-05	0.000193	CcSEcCtD
Rescinnamine—Dermatitis—Prednisolone—hematologic cancer	4.56e-05	0.000193	CcSEcCtD
Rescinnamine—Headache—Prednisolone—hematologic cancer	4.53e-05	0.000192	CcSEcCtD
Rescinnamine—Discomfort—Methotrexate—hematologic cancer	4.53e-05	0.000192	CcSEcCtD
Rescinnamine—ACE—Metabolism of proteins—CCL2—hematologic cancer	4.52e-05	0.00115	CbGpPWpGaD
Rescinnamine—Back pain—Doxorubicin—hematologic cancer	4.51e-05	0.000191	CcSEcCtD
Rescinnamine—Constipation—Prednisone—hematologic cancer	4.5e-05	0.000191	CcSEcCtD
Rescinnamine—Dizziness—Triamcinolone—hematologic cancer	4.4e-05	0.000187	CcSEcCtD
Rescinnamine—Cough—Epirubicin—hematologic cancer	4.4e-05	0.000186	CcSEcCtD
Rescinnamine—Infection—Methotrexate—hematologic cancer	4.36e-05	0.000185	CcSEcCtD
Rescinnamine—Nausea—Etoposide—hematologic cancer	4.36e-05	0.000185	CcSEcCtD
Rescinnamine—Hypertension—Epirubicin—hematologic cancer	4.35e-05	0.000184	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Prednisone—hematologic cancer	4.3e-05	0.000182	CcSEcCtD
Rescinnamine—Nausea—Prednisolone—hematologic cancer	4.3e-05	0.000182	CcSEcCtD
Rescinnamine—Myalgia—Epirubicin—hematologic cancer	4.29e-05	0.000182	CcSEcCtD
Rescinnamine—Pruritus—Betamethasone—hematologic cancer	4.27e-05	0.000181	CcSEcCtD
Rescinnamine—Pruritus—Dexamethasone—hematologic cancer	4.27e-05	0.000181	CcSEcCtD
Rescinnamine—Discomfort—Epirubicin—hematologic cancer	4.24e-05	0.00018	CcSEcCtD
Rescinnamine—Rash—Triamcinolone—hematologic cancer	4.19e-05	0.000178	CcSEcCtD
Rescinnamine—Dermatitis—Triamcinolone—hematologic cancer	4.19e-05	0.000178	CcSEcCtD
Rescinnamine—Urticaria—Prednisone—hematologic cancer	4.18e-05	0.000177	CcSEcCtD
Rescinnamine—Headache—Triamcinolone—hematologic cancer	4.17e-05	0.000177	CcSEcCtD
Rescinnamine—Abdominal pain—Prednisone—hematologic cancer	4.16e-05	0.000176	CcSEcCtD
Rescinnamine—Oedema—Epirubicin—hematologic cancer	4.11e-05	0.000174	CcSEcCtD
Rescinnamine—Infection—Epirubicin—hematologic cancer	4.08e-05	0.000173	CcSEcCtD
Rescinnamine—Cough—Doxorubicin—hematologic cancer	4.07e-05	0.000173	CcSEcCtD
Rescinnamine—Hypertension—Doxorubicin—hematologic cancer	4.02e-05	0.000171	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Methotrexate—hematologic cancer	4e-05	0.00017	CcSEcCtD
Rescinnamine—Dizziness—Dexamethasone—hematologic cancer	3.99e-05	0.000169	CcSEcCtD
Rescinnamine—Dizziness—Betamethasone—hematologic cancer	3.99e-05	0.000169	CcSEcCtD
Rescinnamine—Insomnia—Methotrexate—hematologic cancer	3.97e-05	0.000169	CcSEcCtD
Rescinnamine—Myalgia—Doxorubicin—hematologic cancer	3.97e-05	0.000168	CcSEcCtD
Rescinnamine—Nausea—Triamcinolone—hematologic cancer	3.95e-05	0.000168	CcSEcCtD
Rescinnamine—Paraesthesia—Methotrexate—hematologic cancer	3.94e-05	0.000167	CcSEcCtD
Rescinnamine—Discomfort—Doxorubicin—hematologic cancer	3.92e-05	0.000166	CcSEcCtD
Rescinnamine—Hypersensitivity—Prednisone—hematologic cancer	3.87e-05	0.000164	CcSEcCtD
Rescinnamine—Rash—Betamethasone—hematologic cancer	3.81e-05	0.000161	CcSEcCtD
Rescinnamine—Rash—Dexamethasone—hematologic cancer	3.81e-05	0.000161	CcSEcCtD
Rescinnamine—Oedema—Doxorubicin—hematologic cancer	3.8e-05	0.000161	CcSEcCtD
Rescinnamine—Dermatitis—Betamethasone—hematologic cancer	3.8e-05	0.000161	CcSEcCtD
Rescinnamine—Dermatitis—Dexamethasone—hematologic cancer	3.8e-05	0.000161	CcSEcCtD
Rescinnamine—Headache—Dexamethasone—hematologic cancer	3.78e-05	0.00016	CcSEcCtD
Rescinnamine—Headache—Betamethasone—hematologic cancer	3.78e-05	0.00016	CcSEcCtD
Rescinnamine—Infection—Doxorubicin—hematologic cancer	3.78e-05	0.00016	CcSEcCtD
Rescinnamine—Pain—Methotrexate—hematologic cancer	3.76e-05	0.000159	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Epirubicin—hematologic cancer	3.75e-05	0.000159	CcSEcCtD
Rescinnamine—Pruritus—Prednisone—hematologic cancer	3.72e-05	0.000158	CcSEcCtD
Rescinnamine—Insomnia—Epirubicin—hematologic cancer	3.72e-05	0.000158	CcSEcCtD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—HRAS—hematologic cancer	3.71e-05	0.00094	CbGpPWpGaD
Rescinnamine—Paraesthesia—Epirubicin—hematologic cancer	3.69e-05	0.000157	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Methotrexate—hematologic cancer	3.59e-05	0.000152	CcSEcCtD
Rescinnamine—Nausea—Dexamethasone—hematologic cancer	3.59e-05	0.000152	CcSEcCtD
Rescinnamine—Nausea—Betamethasone—hematologic cancer	3.59e-05	0.000152	CcSEcCtD
Rescinnamine—Pain—Epirubicin—hematologic cancer	3.52e-05	0.000149	CcSEcCtD
Rescinnamine—Constipation—Epirubicin—hematologic cancer	3.52e-05	0.000149	CcSEcCtD
Rescinnamine—Urticaria—Methotrexate—hematologic cancer	3.49e-05	0.000148	CcSEcCtD
Rescinnamine—Dizziness—Prednisone—hematologic cancer	3.48e-05	0.000147	CcSEcCtD
Rescinnamine—Abdominal pain—Methotrexate—hematologic cancer	3.47e-05	0.000147	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	3.47e-05	0.000147	CcSEcCtD
Rescinnamine—Insomnia—Doxorubicin—hematologic cancer	3.44e-05	0.000146	CcSEcCtD
Rescinnamine—Paraesthesia—Doxorubicin—hematologic cancer	3.42e-05	0.000145	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Epirubicin—hematologic cancer	3.36e-05	0.000143	CcSEcCtD
Rescinnamine—Rash—Prednisone—hematologic cancer	3.31e-05	0.000141	CcSEcCtD
Rescinnamine—Dermatitis—Prednisone—hematologic cancer	3.31e-05	0.00014	CcSEcCtD
Rescinnamine—Headache—Prednisone—hematologic cancer	3.29e-05	0.00014	CcSEcCtD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	3.28e-05	0.000831	CbGpPWpGaD
Rescinnamine—Urticaria—Epirubicin—hematologic cancer	3.27e-05	0.000139	CcSEcCtD
Rescinnamine—Pain—Doxorubicin—hematologic cancer	3.25e-05	0.000138	CcSEcCtD
Rescinnamine—Constipation—Doxorubicin—hematologic cancer	3.25e-05	0.000138	CcSEcCtD
Rescinnamine—Abdominal pain—Epirubicin—hematologic cancer	3.25e-05	0.000138	CcSEcCtD
Rescinnamine—Hypersensitivity—Methotrexate—hematologic cancer	3.24e-05	0.000137	CcSEcCtD
Rescinnamine—Nausea—Prednisone—hematologic cancer	3.12e-05	0.000132	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Doxorubicin—hematologic cancer	3.11e-05	0.000132	CcSEcCtD
Rescinnamine—Pruritus—Methotrexate—hematologic cancer	3.11e-05	0.000132	CcSEcCtD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—ALB—hematologic cancer	3.07e-05	0.000778	CbGpPWpGaD
Rescinnamine—Hypersensitivity—Epirubicin—hematologic cancer	3.03e-05	0.000128	CcSEcCtD
Rescinnamine—Urticaria—Doxorubicin—hematologic cancer	3.02e-05	0.000128	CcSEcCtD
Rescinnamine—Abdominal pain—Doxorubicin—hematologic cancer	3.01e-05	0.000128	CcSEcCtD
Rescinnamine—Pruritus—Epirubicin—hematologic cancer	2.91e-05	0.000123	CcSEcCtD
Rescinnamine—Dizziness—Methotrexate—hematologic cancer	2.91e-05	0.000123	CcSEcCtD
Rescinnamine—SLC18A2—Neuronal System—HRAS—hematologic cancer	2.84e-05	0.000721	CbGpPWpGaD
Rescinnamine—Hypersensitivity—Doxorubicin—hematologic cancer	2.8e-05	0.000119	CcSEcCtD
Rescinnamine—Rash—Methotrexate—hematologic cancer	2.77e-05	0.000117	CcSEcCtD
Rescinnamine—Dermatitis—Methotrexate—hematologic cancer	2.77e-05	0.000117	CcSEcCtD
Rescinnamine—Headache—Methotrexate—hematologic cancer	2.75e-05	0.000117	CcSEcCtD
Rescinnamine—Dizziness—Epirubicin—hematologic cancer	2.72e-05	0.000115	CcSEcCtD
Rescinnamine—Pruritus—Doxorubicin—hematologic cancer	2.69e-05	0.000114	CcSEcCtD
Rescinnamine—Nausea—Methotrexate—hematologic cancer	2.61e-05	0.000111	CcSEcCtD
Rescinnamine—Rash—Epirubicin—hematologic cancer	2.59e-05	0.00011	CcSEcCtD
Rescinnamine—Dermatitis—Epirubicin—hematologic cancer	2.59e-05	0.00011	CcSEcCtD
Rescinnamine—Headache—Epirubicin—hematologic cancer	2.58e-05	0.000109	CcSEcCtD
Rescinnamine—Dizziness—Doxorubicin—hematologic cancer	2.52e-05	0.000107	CcSEcCtD
Rescinnamine—Nausea—Epirubicin—hematologic cancer	2.44e-05	0.000104	CcSEcCtD
Rescinnamine—Rash—Doxorubicin—hematologic cancer	2.4e-05	0.000102	CcSEcCtD
Rescinnamine—Dermatitis—Doxorubicin—hematologic cancer	2.4e-05	0.000102	CcSEcCtD
Rescinnamine—Headache—Doxorubicin—hematologic cancer	2.38e-05	0.000101	CcSEcCtD
Rescinnamine—Nausea—Doxorubicin—hematologic cancer	2.26e-05	9.58e-05	CcSEcCtD
